| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NKTR | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP & Chief Commercial Officer | May 16, 2022 | Sale | $3.95 | 4,592 | 18,138 | 223,210 | May 17, 2022, 09:33 PM | |
| NKTR | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP & Chief Commercial Officer | Feb 16, 2022 | Sale | $10.95 | 4,852 | 53,129 | 227,802 | Feb 18, 2022, 06:15 PM | |
| NKTR | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP & Chief Commercial Officer | Nov 16, 2021 | Sale | $13.16 | 6,061 | 79,763 | 194,854 | Nov 17, 2021, 06:06 PM | |
| NKTR | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP & Chief Commercial Officer | Aug 16, 2021 | Sale | $13.83 | 6,192 | 85,635 | 200,915 | Aug 18, 2021, 06:59 PM | |
| NKTR | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP & Chief Commercial Officer | Feb 16, 2021 | Sale | $22.37 | 15,358 | 343,558 | 213,192 | Feb 18, 2021, 07:03 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | NORTHCOTT JOHN | VP, Marketing, Comm Strategy | Mar 02, 2015 | Option Exercise | $0.94 | 3,015 | 2,834 | 8,235 | Mar 03, 2015, 04:08 PM |
Menu